INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

25,799 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$55K
1,793 sh
Jun 24, 2026Jun 26, 2026
Page 287 of 645
← PrevNext →
traded Jun 24, 2026
+2d
SEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
2,410 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
602 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Open-market sale
SELL$301K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$410K
4,062 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale
SELL$871K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$962K
9,445 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$14K
580 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$316K
3,167 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$35K
1,358 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,639
100 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,777
100 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

26
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$39K
3,364 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

26
Greg StantonDSpouse
TCNNFTRULIEVE CANNABIS CORP
Partial sale
SELL$100K – $250KMay 28, 2026Jun 26, 2026
traded May 28, 2026
+29dHouse PTR

Evidence

26
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$19K
1,636 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

25
SG
Swets Larry G JrDirector
GLNDGreenland Energy Co
Open-market purchase
BUY$38K
15.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
160 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

25
SG
Swets Larry G JrDirector
GLNDGreenland Energy Co
Open-market purchase
BUY$10K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4,178
40 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

24
Cleo FieldsDSelf
QNTQuantinuum Inc.
Purchase
BUY$1,001 – $15KJun 4, 2026Jun 26, 2026
traded Jun 4, 2026
+22dHouse PTR

Evidence

24
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$241K
2,362 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
4,160 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

23
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
1,500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

23
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale
SELL$436K
5,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

22
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$1.82M
34.3K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

22
SR
Sakakibara Shan RikuChief Product Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$440K
4,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

22
SR
Sakakibara Shan RikuChief Product Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$440K
4,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

22
DD
Dockery Derrick D.Director
TLSTELOS CORP
Open-market sale
SELL$31K
7,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

21
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$13.72M
188.6K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

20
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
1,040 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$264K
837 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Open-market sale · 10b5-1 plan
SELL$347K
1,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,279 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$890K
2,854 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

18
GD
Graff Marc D.SVP & Chief Financial Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$57K
126 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

18
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.62M
67.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
HJ
Hogan Michael JamesChief Strategy Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$234K
2,800 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$2.82M
11.1K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.06M
16.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
6,944 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence